Mirum Pharmaceuticals (NASDAQ: MIRM) and Incyte (NASDAQ: INCY) announced that the U.S. Food and Drug Administration has approved Atebrioz (zilurgisertib) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA